Ignite Creation Date:
2025-12-25 @ 1:14 AM
Ignite Modification Date:
2026-01-04 @ 4:41 AM
Study NCT ID:
NCT01081093
Status:
COMPLETED
Last Update Posted:
2014-08-06
First Post:
2010-03-04
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Biventricular Pacing in Hypertrophic Cardiomyopathy After Aortic Valve Replacement
Sponsor:
Johann Wolfgang Goethe University Hospital
Organization:
Study Overview
Official Title:
Biventricular Pacing in Hypertrophic Cardiomyopathy After Aortic Valve Replacement
Status:
COMPLETED
Status Verified Date:
2014-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
BIVENT
Brief Summary:
Biventricular Pacing has been shown an improvement of symptoms in patients with heart failure.
A temporary pacing is necessary in patients after cardiac procedures. In patients with hypertrophic cardiomyopathy, a single right ventricular pacing can decrease the cardiac output and blood pressure.
The investigators propose that biventricular pacing in these patients and conditions results in an improvement of symptoms instead of single right pacing.
A temporary pacing is necessary in patients after cardiac procedures. In patients with hypertrophic cardiomyopathy, a single right ventricular pacing can decrease the cardiac output and blood pressure.
The investigators propose that biventricular pacing in these patients and conditions results in an improvement of symptoms instead of single right pacing.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: